Clinical Trial: Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Effect of Treatment Using rhIL-11 in Patients With Thrombocytopenia After Chemotherapy for Childhood Acute Lymphoblastic Leukemia

Brief Summary: The goal of this clinical research study is to find out if rhIL-11(Interleukin 11) may increase the platelet count in Childhood patients with acute lymphocytic leukemia (ALL) who develop low platelet counts while receiving standard CAT(cyclophosphamide+Cytosine arabinoside+mercaptopurine,7d) therapy.